MALDI-target integrated platform for affinity-captured protein digestion

Area of Science:

• Proteomics
• Biomarker Discovery
• Clinical Sample Analysis

Background:

• High-throughput processing is essential for analyzing large cohorts of clinical samples.
• Existing methods for protein immunocapture can be bottlenecks in large-scale studies.

Purpose of the Study:

• To present a novel method for high-throughput protein immunocapture and analysis.
• To validate the robustness of the integrated selective enrichment target (ISET) platform for clinical proteomics.

Main Methods:

• Development and application of the ISET platform for integrated protein biomarker capture, digestion, and cleanup.
• Validation of on-ISET protein digestion using MALDI MS analysis of model proteins.
• Analysis of immunoaffinity captured prostate specific antigen (PSA) from human seminal plasma using on-ISET digestion and MALDI MS/MS.

Main Results:

• The ISET platform successfully integrates multiple steps for efficient protein analysis.
• The on-ISET protein digestion protocol demonstrated robustness across a range of protein quantities (40 fmol to 1 pmol).
• Successful capture and analysis of the disease-associated biomarker PSA from human seminal plasma were achieved.

Conclusions:

• The ISET platform offers a robust and efficient solution for high-throughput proteomic analysis of clinical samples.
• This method facilitates biomarker discovery in large patient cohorts.
• The integrated approach simplifies sample processing for mass spectrometry-based proteomics.